Tritonix.ai

News / US / cnbc

U.S. Battery Supply Chain Efforts Face Steep Hurdles Against Chinese Dominance

Electronic Technology · Electronic Components · cnbc · 2026-09-08

Despite new Department of Energy grants, analysts warn that U.S. efforts to reduce reliance on Chinese battery technology are hampered by insufficient funding and scale.

What Happened

Government Funding Initiatives: The Department of Energy recently allocated $500 million to seven companies focused on battery minerals and manufacturing, marking a modest start under a broader $3 billion program. These grants aim to foster domestic alternatives to Chinese-controlled supply chains, though experts suggest the capital provided is insufficient to bridge the massive competitive gap.

China's Supply Chain Hegemony: China maintains a dominant position across the entire battery lifecycle, controlling the vast majority of mineral refining, cathode production, and anode manufacturing. This concentration of power allows China to exert significant leverage through export controls, leaving U.S. firms struggling to secure essential materials like graphite and lithium.

Scaling and Manufacturing Challenges: While American startups are driving significant innovation in battery technology, they face immense difficulty transitioning from prototypes to mass-market production. Industry observers note that achieving the manufacturing scale and profitability demonstrated by Chinese giants like CATL requires decades of investment and hundreds of billions in capital.

Policy Shifts and Market Outlook: The Trump administration's decision to terminate federal EV tax credits and cancel nearly $24 billion in battery projects has created a challenging environment for domestic development. As China continues to aggressively scale its EV and energy storage sectors, U.S. automakers face increasing pressure to maintain global competitiveness amid a cooling domestic EV market.

Read original

More in Electronic Technology

Qualcomm Partners With Amazon Web Services to Expand AI Data Center Footprint

Electronic Technology · cnbc · 2026-09-08

Qualcomm shares surged 10% following an announcement that the chipmaker will collaborate with Amazon Web Services on custom silicon for AI infrastructure.

QCOM, AMZN, SOXX, NVDA

CTBC Financial Subsidiaries Plan $127M Combined Bid for HanTest IPO

Electronic Technology · cnyes · 2026-09-08

CTBC Bank and Taiwan Life Insurance have announced plans to invest up to NT$4.1 billion in the upcoming IPO of semiconductor equipment firm HanTest.

2891, 7856

Eastek Hits Daily Limit Up at Open: What's Driving the Surge?

Electronic Technology · economic_daily · 2026-09-08

Eastek shares surged to the daily limit immediately upon opening today, drawing significant investor attention to the catalysts behind the sudden rally.

Latest in US

Market Watch: Inflation Data, AI Trends, and Key Analyst Upgrades for Tuesday

Finance · cnbc · 2026-09-08

Jim Cramer highlights key market movements, including Intel's price hikes, refinery upgrades, and the growing influence of AI on hardware demand.

CHRW, FDXF, PSX, MPC, VLO, NVDA, HNGE, @LCO26X, ODFL, SPCX, FDX, SOXX, CRAK, @LCO27G, INTC, AAPL, ETN

Qualcomm Partners With Amazon Web Services to Expand AI Data Center Footprint

Electronic Technology · cnbc · 2026-09-08

Qualcomm shares surged 10% following an announcement that the chipmaker will collaborate with Amazon Web Services on custom silicon for AI infrastructure.

QCOM, AMZN, SOXX, NVDA

Rising Rents and High Home Prices Drive Migration to More Affordable US Cities

Finance · cnbc · 2026-09-08

As for-sale housing remains expensive, renters are increasingly scouting more affordable markets like Buffalo and Chicago, signaling future shifts in real estate demand.

Z

AstraZeneca Reports Positive Late-Stage Data for Tozorakimab in COPD Treatment

Health Technology · cnbc · 2026-09-08

AstraZeneca's experimental COPD drug, tozorakimab, showed significant efficacy in late-stage trials, bolstering the company's multi-billion dollar sales outlook.

AZN, AZN, SNY, GSK, GILD, SNY, REGN, GSK, IBB